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(57) ABSTRACT 
In an automated method for in vivo multiple cell patch 
clamping, cell patch clamping devices are automatically 
moved into position and targeted to multiple corresponding 
cells. Cell contact is determined by analyzing the temporal 
series of measured resistance levels at the clamping devices 
as they are moved. The difference between successive 
resistance levels is computed and compared to a threshold, 
which must be exceeded for a minimum number of compu-
tations before neuron contact is assumed. Pneumatic control 
methods are used to achieve cell-attached or gigaseal for-
mation and subsequent cell break-in, leading to whole-cell 
patch clamp formation. An automated robotic system auto-
matically performs patch clamping in vivo, automatically 
detecting cells according to the methodology by analyzing 
the temporal sequence of electrode impedance changes. By 
continuously monitoring the patching process and rapidly 
executing actions triggered by specific measurements, the 
robot can rapidly find neurons in the living brain and 
establish recordings. 
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AUTOMATED CELL PATCH CLAMPING 
METHOD AND APPARATUS 
RELATED APPLICATIONS 
This application claims the benefit of U.S. Provisional 
Application Ser. No. 61/726,008, filed Nov. 13, 2012, the 
entire disclosure of which is herein incorporated by refer-
ence. 
This application is also a continuation-in-part of U.S. 
patent application Ser. No. 13/676,082, filed Nov. 13, 2012, 
which claims the benefit ofU.S. Provisional Application Ser. 
No. 61/558,841, filed Nov. 11, 2011, the entire disclosures of 
which are herein incorporated by reference. 
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH OR DEVELOPMENT 
This invention was made with U.S. government support 
under Grant Numbers OD002002, NS075421, 1 EY023173, 
and NS067199, awarded by National Institutes of Health, 
and Grant Number EFRI 0835878, awarded by the National 
Science Foundation. The government has certain rights in 
this invention. 
FIELD OF THE TECHNOLOGY 
The present invention relates to whole-cell patch clamp 
electrophysiology and, in particular, to an automated in vivo 
whole-cell patch clamp apparatus and method. 
BACKGROUND 
Whole-cell patch clamp electrophysiology of neurons is a 
"gold standard" technique for high-fidelity analysis of the 
biophysical mechanisms of neural computation and pathol-
ogy. Whole-cell patch clamp electrophysiology of neurons 
in vivo enables the recording of electrical events in cells 
with great precision and supports a wide diversity of mor-
phological and molecular analysis experiments important 
for the understanding of single-cell and network functions in 
the intact brain. However, high levels of skill are required in 
order to perform in vivo patching, and the process is 
time-consuming and painstaking. 
In whole-cell patch clamp electrophysiology, a glass 
pipette electrode is used to gain electrical and molecular 
access to the inside of a cell. It permits high-fidelity record-
ing of electrical activity in neurons embedded within intact 
tissue, such as in brain slices, or in vivo. Whole-cell patch 
clamp recordings [Hamill, 0. P., Marty, A., Neher, E., 
Sakmann, B. & Sigworth, F. J. Improved patch-clamp tech-
niques for high-resolution current recording from cells and 
cell-free membrane patches. Pjlugers Arch 391, 85-100 
(1981); Margrie, T. W., Brecht, M. & Sakmann, B. In vivo, 
low-resistance, whole-cell recordings from neurons in the 
anaesthetized and awake mammalian brain. Pjlugers Arch 
444, 491-498 (2002)] of the electrical activity of neurons in 
vivo, which utilize the glass micropipettes to establish 
electrical and molecular access to the insides of neurons 
embedded in intact tissue, exhibit signal quality and tem-
poral fidelity sufficient to report synaptic and ion-channel 
mediated subthreshold events of importance for understand-
ing how neurons compute, and how their physiology can be 
modulated by brain disorders or pharmaceuticals. In vivo 
patching of cells in intact brain presents several capabilities 
that make it of great use: the recordings present extremely 
high signal-to-noise ratios and thus can be used to reveal 
2 
subthreshold responses such as synaptic or ion channel 
events. Current can be delivered into a pipette to drive or 
silence the cell being recorded, or to support the character-
ization of specific receptors or channels in the cell. 
Whole-cell patch clamping of cells in intact tissue also 
allows for infusion of chemicals and the extraction of cell 
contents. Molecular access to the cell enables infusion of 
dyes for morphological visualization, as well as extraction 
of cell contents for transcriptomic single-cell analysis [Eber-
10 wine, J. et al. Analysis of gene expression in single live 
neurons. Proc Natl Acad Sci USA 89, 3010-3014 (1992)], 
thus enabling integrative analysis of molecular, anatomical, 
and electrophysiological information about single neurons 
in intact tissue. 
15 However, whole-cell patch clamping of cells in intact 
tissue is laborious, being something of an art to perform, 
especially in vivo. Although protocols exist for performing 
whole-cell patch clamp recording in such conditions, much 
practice is required by individual investigators to master the 
20 technique, since each step in the process of looking for a 
neuron and establishing the recording requires intuition as 
well as fast judgment and action. This has limited adoption 
in neuroscience to a small number of labs, and also pre-
cludes systematic and scalable in vivo patch clamping 
25 experiments. 
SUMMARY 
A robot and method for parallel patch clamping of mul-
30 tiple neurons in vivo, known as the "Multipatcher", is 
described. In one aspect, a simple robot automatically per-
forms parallel cell patch clamping in vivo, automatically 
detecting cells by analyzing the temporal sequence of elec-
trode impedance changes. It demonstrates good yield, 
35 throughput, and quality of recording in mouse cortex and 
hippocampus. In another aspect, the present invention is a 
straightforward automated methodology for carrying out in 
vivo patch clamping, and an automated robotic system 
capable of performing this methodology. By continuously 
40 monitoring the patching process and rapidly executing 
actions triggered by specific measurements, the robot can 
rapidly find neurons in the living brain and establish record-
ings. The performance of the robot has been validated in 
both the cortex and hippocampus of anesthetized mice. The 
45 robot achieves yields, cell recording qualities, and opera-
tional speeds that are comparable to, or exceed, those of 
experienced human investigators. This "multipatcher" robot 
not only makes broadly accessible a high-performance scal-
able physiological technique, but also enables systematic 
50 assessments of single cells within neural circuits. It also 
provides a powerful scalable platform for performing single-
cell analyses in other kinds of intact tissue, both natural and 
engineered. 
In one aspect, the present invention is therefore a method 
55 for automated whole-cell patch clamping using an auto-
mated apparatus for cell patch clamping. The method 
includes the steps of localizing the electrodes of a group of 
associated cell patch clamping devices by causing the tips of 
the electrodes to be moved to an appropriate location for cell 
60 hunting, iteratively moving the tips of the electrodes by a 
defined amount, measuring an electrical property, such as 
resistance, at the electrode tips during or after each iteration 
of the step of moving, determining whether or not at least 
one target cell has been encountered by constructing a 
65 temporal series of the resistance measurements during or 
after at least one iteration of the steps of moving and 
measuring, iteratively continuing the steps of moving, mea-
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suring, and determining until the temporal series of electri-
cal property measurements for one or more of the electrodes, 
over a threshold number of consecutive iterations, indicates 
4 
the electrodes to be moved by a defined amount, measuring 
the electrical property at the electrode tips during or after 
each iteration of the step of moving, determining whether or 
not at least one target cell has been encountered by con-
structing a temporal series of the electrical property mea-
surements after each iteration of the steps of moving and 
measuring, iteratively continuing the steps of moving, mea-
suring, and determining until the temporal series of electri-
cal property measurements for one or more of the electrodes, 
a predefined signature of electrode change that has passed a 
pre-set cell detection threshold, pausing the motion of the 
electrodes, initiating connection formation, assessing 
whether or not connection formation has been achieved, 
optionally initiating break-in and formation of whole-cell 
patch clamps if connection formation has been achieved, 
and verifying formation of the whole-cell patch clamps. 10 over a threshold number of consecutive iterations, indicates 
a predefined signature of electrode change that has passed a 
pre-set cell detection threshold, stopping the motion of the 
electrodes, initiating connection formation, assessing 
The method may also include the step of providing strong 
positive pressure to the cell patch clamping devices during 
the step oflocalizing. The method of may also include, after 
completing the step of localizing, the steps of reducing the 
pressure provided to the cell patch clamping devices to low 15 
positive pressure, measuring the electrical property at the 
electrode tips, assessing whether or not the measured elec-
trical property has passed a pre-set tip blockage threshold for 
any electrode, and retracting the associated cell patch clamp-
ing device to indicate tip blockage and failure if the mea- 20 
sured electrical property has passed the pre-set tip blockage 
threshold. The step of initiating connection formation may 
also include the step of releasing the positive pressure 
applied to the cell patch clamping devices. The method may 
also include, after the step of assessing, the steps of applying 25 
suction pressure to the cell patch clamping devices if con-
nection formation has not been achieved and then re-
assessing whether or not connection formation has been 
achieved. The step of initiating break-in and formation 
further may further include applying at least one of suction 
and an electrical pulse to the cell patch clamping devices. 
The method may also include the step of retracting the cell 
patch clamping device to indicate cell location failure if a 
predetermined maximum level for moving the electrode tips 
has been reached. 
In another aspect, the invention is a method for achieving 
and verifying cell contact in an automated electrophysiology 
device by localizing the electrodes of the electrophysiology 
apparatus by causing the tips of the electrodes to be moved 
to an appropriate location for cell hunting, iteratively mov-
ing the tips of the electrodes by a small amount, measuring 
an electrical property at the electrode tips during or after 
each iteration of the step of moving, determining whether or 
not a target cell has been encountered by constructing a 
temporal series of the electrical property measurements after 
each iteration of the steps of moving and measuring, and 
iteratively continuing the steps of moving, measuring, and 
determining until the temporal series of electrical property 
measurements for one or more of the electrodes, over a 
threshold number of consecutive iterations, indicates a pre-
defined signature of electrode change that has passed a 
pre-set cell detection threshold. 
whether or not connection formation has been achieved, 
optionally initiating break-in and formation of whole-cell 
patch clamps if connection formation has been achieved, 
and optionally verifying formation of the whole-cell patch 
clamps. The apparatus may further include a controllable 
plurality of pneumatic valves configured for application of 
pressure and suction to the cell patch clamping devices. 
In yet another aspect, the invention is a method for 
controlling a group of automated cell patch clamping 
devices. In a cell patch formation apparatus that includes a 
group of cell patch clamping devices, each device having an 
associated electrode, a 3-axis linear actuator configured for 
positioning the cell patch clamping device, a patch amplifier 
with computer interface, and a progranimable linear motor 
configured for moving the cell patch clamping device in a 
temporally precise fashion, and a computer interface con-
30 figured for closed-loop control of the programmable motors 
based upon sequences of electrical property measurements 
made at the tips of the electrodes, the method includes 
localizing the electrodes by causing the linear motors to 
move the tips of the electrodes to an appropriate location for 
35 cell hunting, causing the linear motors to iteratively move 
the tips of the recording electrodes by a defined amount, 
measuring an electrical property at the electrode tips during 
or after each iteration of the step of moving, determining 
whether or not at least one target cell has been encountered 
40 by constructing a temporal series of the electrical property 
measurements during or after at least one iteration of the 
steps of moving and measuring, iteratively continuing the 
steps of moving, measuring, and determining until the 
temporal series of electrical property measurements for one 
45 or more of the electrodes, over a threshold number of 
consecutive iterations, indicates a predefined signature of 
electrode change that has passed a pre-set cell detection 
threshold, causing the linear motors to pause the motion of 
the electrodes, initiating connection formation, assessing 
50 whether or not connection formation has been achieved, if 
connection formation has been achieved, optionally initiat-
ing break-in and formation of at least one whole-cell patch 
clamp, and optionally verifying formation of the whole-cell In another aspect, the present invention is an apparatus for 
automated cell patch clamping. The apparatus includes cell 
patch formation apparatus, comprising a group of cell patch 55 
clamping devices, each device having an associated elec-
trode, a 3-axis linear actuator configured for positioning the 
cell patch clamping device, a patch amplifier with computer 
interface, and a programmable linear motor configured for 
moving the cell patch clamping device in a temporally 
precise fashion, and a computer interface configured for 
automated closed-loop control of the progranimable motors 
based upon a temporal series of electrical property measure-
ments made at the tips of the electrodes. The apparatus may 
also include an automated control system configured for 
causing the tips of the electrodes to be moved to an appro-
priate location for cell hunting, iteratively causing the tips of 
patch clamps. 
The cell patch formation apparatus may further include a 
controllable plurality of pneumatic valves configured for 
application of pressure and suction to the cell patch clamp-
ing devices and the method may further include providing 
strong positive pressure from the controllable plurality of 
60 pneumatic valves to the cell patch clamping devices during 
the step of localizing, reducing the pressure provided to the 
cell patch clamping devices to low positive pressure after 
completing the step of localizing, measuring the electrical 
property at the electrode tips, assessing whether or not the 
65 measured electrical property passed a pre-set tip blockage 
threshold, retracting the associated cell patch clamping 
devices to indicate tip blockage and failure if the measured 
US 9,498,293 B2 
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electrical property has passed the pre-set tip blockage 
threshold, releasing the positive pressure applied to the cell 
patch clamping devices during the step of initiating connec-
tion formation, applying suction pressure from the control-
lable plurality of pneumatic valves to the cell patch clamp-
ing devices if connection formation has not been achieved, 
re-assessing whether or not connection formation has been 
achieved, and initiating break-in and cell patch clamp for-
mation by applying suction pressure from the controllable 
plurality of pneumatic valves and/or an electrical pulse to 10 
the cell patch clamping devices. 
FIGS. 14A-C are current traces showing the results of 
investigation of synaptic connectivity between whole cell 
patched neurons using the neurons recorded in FIGS. 13A-
B. 
DETAILED DESCRIPTION 
The parent application, U.S. patent application Ser. No. 
13/676,082, filed Nov. 13, 2012, is incorporated in its 
entirety herein. In U.S. patent application Ser. No. 13/676, 
082, a method was described by which patch clamping in 
vivo was reduced to a computer process that controlled the 
"autopatcher", a robot capable of conducting blind in vivo 
patch clamping in an automated fashion. The utility of the BRIEF DESCRIPTION OF THE DRAWINGS 
Other aspects, advantages and novel features of the inven-
tion will become more apparent from the following detailed 
description of the invention when considered in conjunction 
with the accompanying drawings wherein: 
FIG. 1 is a schematic depiction of a preferred embodiment 
of an apparatus according to, and for carrying out, the 
present invention; 
FIG. 2 is a schematic depicting exemplary configurations 
of pneumatic valve banks employed in the apparatus of FIG. 
1 during the stages of multipatcher operation, according to 
one aspect of the present invention; 
FIG. 3 is a visual depiction of the four stages of the 
general in vivo patch process for a single cell, carried out 
using the apparatus and methodology of the present inven-
tion; 
FIG. 4 is a visual depiction of the stages of the in vivo 
multipatching process for patching multiple cells, carried 
out using the apparatus and methodology of the present 
invention; 
FIG. 5 depicts a prototype implementation of the non-end 
actuator components of a multipatcher system according to 
one aspect of the present invention; 
15 autopatcher was demonstrated for obtaining recordings in 
both the cortex and hippocampus of the anesthetized mouse 
brain, achieving high yields (-30% of overall attempts) and 
recording qualities that were comparable to those of trained 
humans. The algorithmic nature of the procedure and the 
20 simple robotics needed to implement the autopatcher opened 
up the ability to actuate many pipettes within a single brain, 
and to perform parallel recordings of neurons or other cells 
within a single living network. 
Building off the discovery that blind in vivo whole-cell 
25 patching could be reduced to a reliable and stereotyped 
process, the core hardware and software components of the 
single charmel autopatcher were used to develop the "mul-
tipatcher", a robot capable patch clamping sets of neurons 
simultaneously in vivo. An exemplary prototype multi-
30 patcher consisting of four independently controlled patch 
pipettes was constructed. This multipatching robot was 
capable of achieving stable whole cell recordings from pairs 
and triplet of neurons, with a 59% success rate of whole cell 
recordings from one or more neurons, and a 30.7% success 
35 rate of recording from two or more neurons. The trials 
typically took just 2-3 minutes for each charmel, and taking 
10-11 minutes for a full trial. Simultaneous whole cell 
recordings could be carried from these neurons for up to 90 
FIG. 6 is a photograph depicting prototype implementa-
tions and radial arrangement of four end actuator modules of 40 
a multipatcher system according to one aspect of the present 
minutes. The processs used for multipatching can be gen-
eralized to control arbitrarily large number of electrodes; 
additionally, the high yield, throughput and automation of 
invention; 
FIG. 7 is a photomicrograph of a set of 4 pipettes tips 
positioned for targeting the same brain region in an exem-
plary prototype implementation of the present invention; 
FIG. 8 is a schematic illustration of an exemplary pressure 
regulator board according to one aspect of the present 
invention; 
FIG. 9 is a schematic illustration of an exemplary pneu-
matic system for a single channel according to one aspect of 
the present invention; 
FIGS. lOA-C are visual depictions of the stages of three 
embodiments of the in vivo multipatching process carried 
out using the apparatus and methodology of the present 
invention; 
FIGS. llA-C depict a flowchart showing the steps of a 
preferred embodiment of the complete generalized auto-
mated process for patching multiple neurons in vivo accord-
ing to one aspect of the invention; 
FIG. 12 is a graph of representative traces of pipette 
resistances recorded by the prototype multipatcher during a 
successful multipatcher trial; 
FIGS. 13A and 13 B depict exemplary whole cell current 
clamp recordings and sub-threshold membrane potential 
fluctuations, respectively, in three neurons that were 
recorded simultaneously during the trial depicted in FIG. 12; 
and 
complex set of tasks enables a practical solution for con-
ducting patch clamp studies in potentially dozens of inter-
connected neurons in vivo for the first time. This will enable 
45 a more systematic assessment of how neurons work together 
to implement computations, and how they malfunction in 
diseased states. 
The preferred embodiment of the multipatcher robot 
shares many of its core components with the single channel 
50 autopatcher described in U.S. patent application Ser. No. 
13/676,082. A schematic depiction of a preferred embodi-
ment of an apparatus according to, and for carrying out, the 
present invention is shown in FIG. 1, which is a schematic 
of the robotic system ("the multipatcher") used to perform 
55 the multipatching process described later. 
As shown in FIG. 1, an exemplary embodiment of the 
system has four end actuator modules 101, 102, 103, 104, 
each comprising a 3-axis linear actuator 105 and an addi-
tional programmable linear motor 110. The system employs 
60 a conventional in vivo patch setup, including pipette 115, 
pipette holder 120, headstage 125 mounted on each end 
actuator module 101, 102, 103, 104, 3-axis linear actuator 
105 with control joystick 127, patch amplifier 129 connected 
to patch amplifier computer interface board 130 by switch 
65 box 131, and computer 135. The apparatus shown in FIG. 1 
is set up for patching on headfixed mouse 140. For simplic-
ity, connections from only one such system to the patch 
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the robot employs a set of valves connected to pressure 
reservoirs to provide positive pressure during pipette inser-
tion into the brain and negative pressure as necessary to 
result in gigaseal formation and attainment of the whole cell 
state. 
FIG. 2 is a schematic depicting the configurations of the 
pneumatic valve banks during the stages of multipatcher 
operation. In FIG. 2, "x" represents closed valves and lines 
depict connectivity of volumes at the same pressure. During 
regional pipette localization stage 210, positive pressure 215 
(800-1,000 mBar) is connected to the pipette. This is also the 
configuration realized when the valves are not powered. 
During neuron hunting stage 230, low positive pressure 235 
(25-30 mBar) is connected to the pipette. During gigaseal 
amplifier 129, the motors controller 150, and the joystick 
127 are highlighted in FIG. 1. The robot of FIG. 1 is 
equipped with three simple modules: programmable linear 
motors 110 with linear motors controller 150, which func-
tions to move pipettes 115 up and down in a temporally 
precise fashion, pressure switch board 158 and pressure 
regulator board 159 for pressure control, and secondary 
computer interface board 175 that enables closed-loop con-
trol of motors 110 based upon sequences of pipette resis-
tance measurements. If the vertical axis of 3-axis linear 10 
actuator 105 is computer-controlled, programmable linear 
motor 110 with linear motor controller 150 can be omitted, 
and if patch amplifier 129 plus patch amplifier computer 
interface board 130 provides direct access to measurements, 
secondary computer interface board 175 can be omitted. 
Each headstage 125 is connected to a patch amplifier 129, 
which routes the signals to computer 135 via the two 
computer interface boards, patch amplifier computer inter-
face board 130 and secondary computer interface board 175. 
Secondary computer interface board 175 is dedicated to data 20 
acquisition, while patch amplifier computer interface board 
130 is used for executing the multipatching process. The 
headstages communicate electrically with amplifiers and the 
computer interface board, which both records the neural 
signals and delivers neural control signals to the headstages. 25 
Actuation of motors is achieved using linear motor control-
15 formation stage 250, suction pressure 255 (-15 to -20 mBar; 
dotted line 260) or atmospheric pressure 265 (solid line 270) 
is applied. During the break-in stage, suction pressure 255 is 
also applied. 
ler 150, which is commanded by computer 135, thus com-
pleting the closed loop control system. There is a pneumatic 
pressure control system, consisting of pressure regulation 
board 159 and pressure switch board 158, which takes in 30 
pressurized air stored in a large reservoir and converts that 
into different regulated pressure states such as high positive 
pressure, low positive pressure and suction. These regulated 
pressure states can be applied to the pipettes at different time 
points during the multipatching process. Pressure switch- 35 
board 158, which has a controllable bank of pneumatic 
valves and analog pressure regulators, is controlled using 
secondary computer interface board 175. 
While specific parts and implementation details are 
described herein with respect to the embodiment of FIG. 1, 40 
it will be clear to one of skill in the art of the invention that 
The different stages of the in vivo multi patching process 
were optimized by building upon the autopatcher process 
described in U.S. patent application Ser. No. 13/676,082. 
FIG. 3 depicts visually the four stages of the general in vivo 
patch process: regional pipette localization stage 310, during 
which pipette 320 in holder 325 is lowered to target zone 
327 in the brain; neuron hunting stage 330, during which 
pipette 320 is advanced until neuron 340 is detected via a 
change in pipette resistance; gigaseal formation stage 350, 
during which gigaseal cell-attached patch state 375 is 
achieved; and break-in stage 380, during which the whole 
cell configuration is achieved. 
The process by which the multipatching robot establishes 
whole cell recordings in multiple neurons is illustrated in 
FIG. 4 for a 4-channel embodiment. Before the robot is 
started, pipettes 405 are installed into channels 410, 411, 
412, 413 of the multipatcher, and the pressure is set to high 
positive pressure state in all of them. The pipettes 405 are 
then positioned in the craniotomy such that their tips enter 
and probe a brain area 415 within a few hundred microm-
eters of each other. To begin regional pipette localization, an 
initial assessment 420 of the pipettes' electrical resistance is 
carried out to ensure the pipettes are within an acceptable 
range for patch clamping-typically between 3-9 MQ. The 
robot then lowers 425 all the pipettes in a serial fashion to 
the desired depths set by the experimenter. It is possible to 
many other comparable parts, software, and implementation 
methodologies exist and would be equally suitable for use in 
the present invention. It will further be clear to one of skill 
in the art that the system can easily be scaled up n-fold. 45 localize different pipettes to different depths within the 
cortex. Once all the pipettes have been lowered 430, they are 
checked for tip fouling or blockage. If a pipette 412 has a 
clogged or fouled tip, the corresponding channel is deacti-
In the prototype embodiment, each recording probe is a 
glass pipette with a fine tip, filled with conductive saline 
solution. A silver chloride wire is inserted inside the pipette 
electrically connects the conductive solution to an amplify-
ing headstage. Each headstage is mounted on a program- 50 
mable linear motor, which is in turn held in place using a 
3-axes linear manipulator. The assembly of the program-
mable linear motor, and the 3-axes linear manipulator make 
up the end actuator modules, four of which are arranged in 
vated 435, and plays no further part in the multipatching 
process. 
a radial pattern so as to be able to position an array of 4 55 
pipettes, with their distal ends in close proximity to each 
other. 
Next, the robot enters the "neuron hunting and gigaseal-
ing mode", in which the pipettes are advanced in small 
increments until each detects a neuron via signature changes 
in pipette resistance, at which time the pipettes stop moving 
and gigaseal formation is attempted. As shown in FIG. 4, the 
robot moves 440 all the pipettes in active channels in small 
incremental steps (2-3 µm), after which it sends 445 a series 
of predefined square wave voltage pulses (e.g. 10 mV at 10 
Hz, with offset voltage set at 0 m V) to the different pipettes, 
The robot of FIG. 1 monitors pipette resistance as the 
pipettes are lowered into the brain, and automatically moves 
the pipettes in incremental steps via the linear actuator. In 
one embodiment, the pipette resistance monitoring can be 
performed by a traditional patch amplifier and digitizer, and 
the 3-axis linear actuator typically used for in vivo patching 
can be used as the robotic actuator. For flexibility, an 
optional additional computer interface board was added to 
support pipette resistance monitoring, and an additional 
linear actuator for pipette movement. In some embodiments, 
60 and measures the resultant current traces. This is used to 
compute the resistance values of the pipettes. This two-step 
process is repeated while looking for signature trends in 
resistance traces in one or more channels that indicate 
suitable contact with a neuron 450 for patch clamping 
65 (analogous to the "neuron hunting" stage in the autopatcher 
operation). After detecting this signature, the robot halts the 
movement of pipettes in all channels, and attempts to 
US 9,498,293 B2 
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establish 455 a gigaseal in the channels that have encoun-
tered a neuron (the "gigasealing" stage in the autopatcher). 
After a gigasealing attempt has been carried out in a par-
ticular channel, its motor is deactivated, and the rest of the 
pipettes resume neuron hunting. This process is repeated 
until all the pipettes have encountered neurons and 
attempted gigasealing 460. At this point, the channels 465 
that have successfully formed gigaseals are selected 470 and 
the robot applied pulses of suction until it successfully 
breaks into the gigasealed cells (the "synchronized break-in" 
stage). 
10 
mmx 1 mm on top of the brain surface. It is desirable to get 
the pipette tips as close to each other as possible, so as to 
target neurons within the same microcircuit (<200 µm). 
With an angled approach, if the pipettes are lowered into 
the brain to depths >700 µm, the pipettes can be positioned 
within a millimeter of each other with this prototype system. 
Positioning them closer can sometimes result in pipettes 
colliding with each other during a trial, and was thus not 
attempted. The programmable linear motors in each of the 
10 four channels are connected to a multiplexing switchboard 
(PZC-SB, Newport; FIGS. 1 and 6). All motors are con-
trolled via a single motor controller (PZC200, Newport Inc). 
The PZC200 motor controller is in turn connected to the 
The ability of the robot to perform these tasks in an 
automated and parallel fashion results in a degree of scal-
ability that human operators are not capable of performing 
manually. Simultaneous, parallel execution of multiple time- 15 
point tasks such as lowering multiple pipettes in small 
increments, monitoring of resistance values in multiple 
channels, and identification of signature neuron contact 
trends become increasingly complex tasks for human experi-
menters and thus become unmanageable to perform manu- 20 
ally when the number of pipettes is scaled beyond 2 or 3 
channels. Further, automation enables a fine control of the 
time scales over which different tasks and decisions are 
executed. For example, it is possible to synchronize events 
such as breaking into multiple neurons so that the all the 
gigasealed neurons can obtain whole cell state at the same 
time, thus enabling the experimenter to maximize the time 
duration of simultaneous whole cell recordings and normal-
computer through a serial COM port. This architecture 
allows up to 8 channels to be selected and controlled by the 
switch box using a single serial port in the computer. 
Signal Interfacing with computer. Signals from the head-
stages ire sent to two 2-channel patch amplifiers (Multi-
clamp 700B, Molecular Devices) that connect the patch 
headstages to a computer through a Digidata 1440A analog/ 
digital interface board (Molecular Devices). In a similar 
fashion to the autopatcher, an additional data acquisition 
(DAQ) board ( cDAQ-917 4 chassis with modules NI 9215 
for analog inputs and NI 9264 for analog outputs, National 
25 Instruments Inc) is connected to the computer via a USB 
port and to the patch amplifier through BNC cables, for 
control of patch pipette voltage commands and acquisition 
of pipette current data during the execution of the multi-
patcher process. During multipatcher operation, the cDAQ-ize the effects of cell dialysis that occur starting from the 
moment intracellular access is obtained. 
Multipatcher robot construction. The multipatcher hard-
ware was assembled using the basic template of the auto-
patcher robot described in U.S. patent application Ser. No. 
13/676,082 and replicating the end actuators four-fold. 
Modifications were made to the pneumatic systems so that 
a central pressure control system could be used for inde-
pendent pressure modulation in all four channels. These are 
described in detail below. 
30 9174 board sends commands to the patch amplifiers; after 
acquisition of cell-attached or whole-cell-patched neurons, 
the patch amplifiers will instead receive commands from the 
Digidata. A software-controlled co-axial BNC relays 
(CX230, Tohtsu) is used for driving signal switching 
35 between the cDAQ-9174 and the Digidata. The patch ampli-
fier signals are split and streamed simultaneously to the 
analog input ports of both the cDAQ-9174 and the Digidata 
throughout and after patching. The multipatcher program is 
FIG. 5 depicts a prototype implementation of the non-end 
actuator components of a multipatcher system according to 40 
one aspect of the present invention. Shown in FIG. 5 are 
patch amplifiers 510, primary digitizer 520, secondary digi-
tizer 530, switch boxes 540, motor controllers 550, pressure 
regulator board 560, and pressure switch board 570. 
coded in, and runs on, Labview 2011 (National Instruments). 
The cDAQ-9174 sampled each channel of patch ampli-
fiers at 15 KHz and without any applied scaling factor, and 
then filtered the signal using a moving average smoothening 
filter (half width, 6 samples, with triangular envelope), and 
the amplitude of the current pulses was measured using the 
Actuator system. FIG. 6 is a photograph depicting pro-
totype implementations and radial arrangement of four end 
actuator modules of a multipatcher system according to one 
aspect of the present invention. The pipette actuator modules 
are of the same configuration as the single channel system. 
Briefly, each module comprises a 3-axis linear actuator 610 
(MPC285, Sutter Instruments Inc) for holding the patch 
headstage. For programmable actuation of the pipette in the 
tilt axis, a programmable linear motor 620 (PZC12, New-
port) is mounted onto the 3-axis linear actuator 610. The tilt 
axis actuator is mounted at an angle of 45 degrees to the 
vertical. The headstage is in turn mounted on programmable 
linear motor 620 through a custom mounting plate. The 
anesthetized mouse is head fixed using custom holder 630, 
and pipettes are positioned using a stereomicroscope for 
visualization. Four such actuator modules are placed in close 
proximity to each other in a radial fashion, forming an 
asymmetric array for actuating pipettes. 
FIG. 7 is a photomicrograph of a set of 4 pipette tips 710 
from the apparatus of FIG. 6, positioned within a 1 mm 
square area for targeting the same brain region in the cortex. 
The scale bar indicates 1.5 mm. In this configuration, it was 
possible to position four patch pipette tips in an array of 1 
45 peak-to-peak measurement function of Labview. During 
gigasealing operations, where currents of the orders of 5-10 
pA were measured, an additional exponential filter (decay 
rate=0.001 seconds) was used to filter out any stray pipette 
capacitance traces. For resistance measurements, the ampli-
50 fiers were set in voltage clamp mode using the Multiclamp 
commander software (Molecular Devices). Square wave of 
voltage traces were applied: 10 m V in amplitude, at 10 Hz, 
to the pipettes via the cDAQ-9174 analog outputs. Resis-
tance values were then computed, by dividing applied volt-
55 age by the peak-to-peak current observed, for 5 consecutive 
voltage pulses, and then these 5 values were averaged. 
During gigasealing and break-in stages of the robot opera-
tion, offsets ranging from 0 to - 70 m V were applied to the 
10 m V, 10 Hz square waveforms to apply the requisite 
60 holding potentials needed by the multipatcher process. Mul-
tipatched neurons were recorded using Clampex software 
(Molecular Devices). Signals were acquired at standard rates 
(e.g., 30-50 KHz), and low-pass filtered (Bessel filter, 10 
KHz cutoff). All data was analyzed using Clampfit software 
65 (Molecular Devices) and MATLAB (Mathworks). 
Pneumatic system. In a preferred embodiment, the pneu-
matic system consists of two boards: an analog pressure 
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regulator board (159, FIG. 1) and a pressure switching board 
(158, FIG. 1). A schematic illustration of an exemplary 
pressure regulator board is shown in FIG. 8, which depicts 
the regulation of pressure to different pipettes via valve 
banks 805, 810, 815 using a common pressure source. It 
consists of three manual pressure down-regulators (Mcmas-
ter Can) connected to a common wall pressure source 820 
outputting a pressure of -5500 mBar. The wall pressure 
source is down regulated, or converted to a vacuum pres-
sure, and routed to the designated input ports of the valve 10 
switching board. Each valve switching board consists of 
multiple valve banks (FIG. 2) that can be controlled using 
the secondary digitizer (FIG. 1) to set a desired pressure 
state in a pipette. In the exemplary embodiment, the wall 
pressure is down regulated to three levels, 1 Bar, 100 mBar, 15 
and -500 mBar. The 1 Bar regulated pressure is connected 
to an electronic pressure regulator 825 (990-005101-015, 
Parker) for setting to high positive pressure state (i.e. 
800-1000 mBar). The 100 mBar regulated pressure is simi-
larly connected a second pressure regulator 830 (990- 20 
005101-002, Parker) for setting the low positive pressure 
state (15-20 mBar). The -500 mBar regulated pressure 
source is connected to venturi vacuum generator 840 
(AVR038H, Air-Vac ), which generates a vacuum pressure of 
300 mBar, and that is connected to electronically-controlled 25 
vacuum pressure regulator 845 (990-005203-005, Parker). 
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errors. Thus, the resistance measurement events in all chan-
nels need to be synchronized during the entire process of 
neuron hunting. Secondly, this approach does not take into 
consideration the brain tissue displacement caused by the 
motion of multiple pipettes in the brain. For establishing 
stable gigaseals, it is critical to prevent any relative motion 
between the pipette tip and the cell during the gigasealing 
process. Since encountering a neuron during blind in vivo 
patch clamping is a random process, in a system with 
multiple autopatchers rumiing independently, different 
pipettes encounter neurons at different time points. Move-
ment of pipettes seeking neurons during neuron hunting 
cause tissue displacement, which hinders the proper estab-
lishment of gigaseals in pipettes that have already encoun-
tered neurons. Large displacements can also dislodge neu-
rons that are already fully gigasealed onto pipettes. Thus, 
strategies are required to minimize the amount of tissue 
displacement during the neuron hunting and gigasealing 
stages of the process. Other factors considered included 
hardware and its limitations on parallelization, time and 
throughput considerations, other physiologial factors such as 
cells dying when exposed to intracellular solution outside, 
and synchronized gigasealing vs. asynchronous. 
One of the steps taken to mitigate the tissue displacement 
issue was to perform the regional pipette localization step 
for all the electrodes in a single step. Thus, each pipette can 
be lowered to the desired depth, and then neuron hunting in 
all charmels can start simultaneously. This is shown in the 
"regional pipette localization" section of the flowchart of the 
FIG. 9 is an exemplary pneumatic system for a single 
channel. Shown in FIG. 9 are high positive pressure regu-
lator 910, low positive pressure regulator 920, low vacuum 
source 930, pressure outlet 940, and pressure inlet 950. 30 preferred embodiment of the multipatcher process (FIGS. 
llA-C). Once the pipettes have been installed and posi-
tioned in the craniotomies, the multipatcher program is 
started. At this point the depths for all the pipettes Z0 , (i=l, 
In the prototype embodiment, the pressure outputs of the 
three electronic pressure regulators were controlled using 
analog voltages (0-5 V) set manually using potentiometers at 
800 mBar (high positive pressure), 20-25 mBar (low posi-
tive pressure state), and -15 to -25 mBar (suction state). For 35 
breaking-in, the suction pressure was set to vacuum pres-
sures between -150 mBar to -250 mBar. The pressure 
outputs were measured using digital manometers ( 4756-FM, 
Dwyer) and connected to the input manifolds of the pressure 
switchboard. 
2, 3 and 4) are denoted as zero by the program. Then the 
baseline pipette resistances R20, in the ACSF or saline bath 
are recorded. The pipettes are then lowered to the desired 
depths at a speed of -200 mm/s. Pipettes in different 
channels can be lowered to different desired depths, thereby 
allowing simultaneous recordings from different layers of 
The pressure switchboard in the prototype consisted of 4 
sets of valve banks, with each valve bank, consisting of 3 
solenoid valves (2-input, I-output, LHDA0533215H-A, Lee 
Company), as shown in FIG. 2. The input ports in each of the 
three valves making up the valve bank can be closed or 
opened using a TTL command from the secondary interface 
board. 
40 the cortex, or even different regions of the brain. Once 
lowered to depth, the pressures in the pipettes are decreased 
to low positive pressure state (-20-25 mBar) and the pipette 
resistances Rzrn assessed for a second time. The values of 
Rzrn and R20, are compared and if resistance increases 
45 greater than 0.35 MQ are detected in any of the charmels, the 
pipette tips are deemed blocked or fouled, and those chan-
nels are deactivated and play no further part in the multi-
patcher trial. If all pipettes are found to be inadequate for 
patching, the program stops, and a new trial has to be started. 
Derivation of a process for multi patching. The process for 
multipatching in vivo was formulated using the autopatcher 
process as a basic template and modifying it for parallel 
control of multiple pipettes. The primary objective of any 
process used for parallel patch clamping in vivo is to 
establish whole cell recordings from as many neurons as 
possible, ideally ensuring arbitrary scalability in a short time 
period. The simplest implementation of a parallel patch 
clamping system is to introduce the desired number of fully 
independent autopatcher units simultaneously into the brain, 
with the physical constraint being the placement of the 
pipettes in the desired positions in the brain. Such an 
independently deployed system would ensure that n number 60 
of charmels conduct autopatching trials in the same average 
time as it would take for a single charmel autopatcher (5+1 
minute). 
50 It was found that pipettes got fouled at a rate of 18.2% (n=28 
out of 156 pipettes in 39 trials), which is comparable to the 
rate of pipette blockage in the autopatcher. By lowering all 
the pipettes into the regions of interest in a single step, large 
macroscopic displacements of pipettes (and the correspond-
55 ing tissue displacement) are eliminated. This completes the 
"regional pipette localization" stage of the multipatcher 
process. The multi patcher next seeks out neurons to gigaseal 
and break-in to in order to establish whole cell recordings. 
However, in actual practice this strategy encounters two 
issues. Firstly, the movement of motors during neuron 65 
hunting results in electrical noise, and when coincident with 
the resistance measurements in other channels, results in 
Two factors needed to be taken into consideration while 
formulating methodologiess for the subsequent stages of 
patch clamping. Firstly, it is advantageous to perform all the 
steps of neuron hunting, gigasealing, and break-in in a 
parallel manner, so as to reduce the time duration of the 
experiment. Secondly, as the number of channels is scaled 
up, the supporting hardware required for independent pres-
sure control scales up proportionally. Each charmel of the 
multipatcher requires three solenoid valves and three corre-
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sponding TTL control channels. Thus, for n number of 
channels, this number would be 3n. When dealing with large 
number of channels (>50), it becomes impractical to have 
independent control over the pressures for each individual 
channel. One way to simplify this requirement is to syn-
chronize the gigasealing events for all the channels. In this 
way, the pressures of all the systems can be switched 
between different states at the same time, i.e. from low 
positive to atmospheric pressure, followed by suction appli-
cation using just one set of solenoid switch valves. 
Different means to achieve the end whole cell state in all 
pipettes in as synchronized a manner as possible were 
explored. FIGS. lOA-C are visual depictions of the stages of 
three different embodiments of the in vivo multipatching 
process carried out using the apparatus and methodology of 
the present invention. In the methods depicted in FIGS. lOA 
and lOB, all cells reached gigasealed state synchronously, 
while in FIG. lOC, only the break-in stage was synchro-
nized. In FIG. lOA, each pipette stops when neurons are 
encountered, in FIG. lOB the pipettes are retracted back by 
a fixed distance after contact, and in FIG. lOC pipettes 
attempt gigasealing immediately upon encountering neu-
rons. In FIGS. lOA-C, pipettes that are depicted as faded 
represent those that were deactivated at the end of the 
regional pipette localization stage and play no part in the 
process. 
A simple extension of the autopatcher process is shown in 
FIG. lOA. The active pipettes 1002, 1004, 1006 are first 
actuated 1010 in steps of 2 µm, followed by an assessment 
of their pipette resistances. This process is repeated itera-
tively, until one or more pipettes encounters 1015 a neuron 
1017, as detected by the criterion used by the autopatcher, 
14 
exposure of the neurons to the intracellular pipette solution 
ejected out of the pipette, while waiting for the rest of the 
channels to find neurons, possibly had a deleterious effect on 
the neurons and resulted in lower rates of gigasealing. 
To mitigate this effect, a second method, shown in FIG. 
lOB, was implemented. In this procedure, the multipatcher 
proceeds along the same lines as the method of FIG. lOA, 
with the active pipettes 1002, 1004, 1006 being actuated 
1010 in steps of 2 µm, followed by an assessment of their 
10 pipette resistances, until a neuron 1035 is encountered at one 
of the channels, at which time, the pipette is retracted by 30 
µm and stopped 1040. A value of30 µm was chosen because 
that was the minimum distance the pipettes needed to be 
refracted before the resistance measurement decreased to the 
15 average baseline value (n=15 trials). This positions the tip at 
a distance where the ejection of the intracellular solution has 
no effect. This process is repeated for all the active pipettes, 
so that at the end of neuron hunting 1045, the relative 
positions of all the pipettes, and the corresponding neurons 
20 
they encountered are the same (-30 µm, after accounting for 
tissue displacement). As a final neuron-hunting step, all 
pipettes are moved forward 1045 by the same distance (30 
µm), and gigasealing is attempted synchronously 1050, 
followed by synchronized break-in 1055. 
The method of FIG. lOB yielded a success rate for 
25 gigasealing of -20% (12 out of 59 attempts in 17 trials, with 
9 pipettes deactivated at the end of regional pipette local-
ization stage due to tip blockage). Again, this was much less 
than what would be expected when using the autopatcher 
process. The resistance measurement traces for this method 
30 were analyzed, and it was found that, after the final neuron 
hunting step when all pipettes advanced forward by 30 µm, 
resistances went back to the elevated values indicated by 
contact with neurons in only 45.7% (27/59 attempts), again i.e. monotonic increase in pipette resistance greater than 250 
kQ over two consecutive actuation steps. Once a neuron 
1017 is detected 1015, the corresponding motor is simply 35 
deactivated and the rest of the pipettes 1002, 1006 continue 
the process of neuron hunting, until all pipettes encounter 
neurons and stop 1020. At this time, the pressure in all 
pipettes 1002, 1004, 1006 is simultaneously released and 
gigasealing is attempted 1025, in a manner identical to the 
autopatcher, followed by synchronized break-in 1030. This 
process is very similar to that employed by the autopatcher, 
but required a wait before the release of positive pressure in 
order to permit gigasealing in all of the channels. 
indicating that tissue displacement effects were in play. 
As has been observed previously, once gigasealed cell 
attached or whole cell stage has been achieved, the configu-
ration is remarkably stable against motion artifacts. This has 
been used previously to record in the whole cell state from 
head fixed, freely moving animals. Several groups have also 
shown that it is possible to carry out loose cell attached 
40 
recordings for tens of minutes to hours. Further, from whole 
cell stage, pipettes can be retracted for up to 50-60 µm before 
an outside out patch is established. Using this property, a 
third method was implemented wherein, as shown in FIG. 
1 OC, once a pipette encounters a neuron, the program pauses In 19 trials using the method of FIG. lOA (in n=3 mice), 
where three or more active pipettes performed the neuron 
hunting and gigasealing tasks, the multipatcher established 
successful gigaseals 22% of the time (15 out of a total of 68 
attempts in 19 trials, with 8 out of 76 pipettes having been 
deactivated at the end of regional pipette localization stage 
due to tip blockage). The pipettes reaching neurons last, and 
thereby immediately going into gigasealing, successfully 
formed gigaseals 36.8% of the time (7 out of 19 attempts). 
45 neuron hunting in all channels and attempts gigasealing in 
the channel that has encountered a neuron. 
As shown in FIG. lOC, in this method, once the robot 
enters the neuron hunting and gigasealing stage 1060, it 
lowers 1010 pipettes 1002, 1004, 1006 in the active channels 
50 by 2 µm in a serial fashion, followed by an assessment of the 
pipette resistances, until a neuron 1062 is encountered at one 
of the channels. These two tasks are performed repetitively, 
while constantly looking for time-series trends in resistance 
measurements that are indicative of contact with a neuron. 
In the rest of attempts, successful gigaseals were formed 
16.3% of the time (8 out of a possible 49 attempts). This 
number is significantly lower that what was previously 
found using the autopatcher. The resistance traces in this 
second set were analyzed, and it was found that, in some of 
the traces, the resistance values decreased to the baseline 
readings obtained before contact with a neuron during the 
course of waiting for pipettes in other channels (20% of the 
time, 10 out of 49 trials). This indicates that the tissue 60 
displacements caused by the motion of other pipettes in the 
brain was large enough to dislodge neurons from the opti-
mum relative positions with respect to the neurons for 
gigasealing. Further, only 20.5% (8 out of the remaining 39) 
55 These trends are typically monotonic increases in pipette 
resistance over 0.2-0.25 MQ within three measurements. 
of the pipettes established successful gigaseals, even when 65 
elevated resistance readings (indicating contact with a neu-
ron) were observed. It was hypothesized that the constant 
Whenever a channel positively encounters a neuron 1062, 
pipette actuation in all channels is stopped and gigasealing 
protocol 1070 is initiated. 
The multipatcher waits 10 seconds to see if the pipette 
resistance decays back to baseline value. If it does, the 
program restarts neuron hunting 1010. Otherwise, the pro-
gram releases positive pressure in the pipette, waits 5 
seconds, and applies suction pressure for 10 seconds. Once 
the suction pressure is released, the holding potential is 
stepped down to -30 m V, and ramped down from that value 
to - 70 m V over the next 30 seconds. This completes the 
"gigasealing" attempt for that pipette. Once the gigasealing 
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protocol 1070 is completed in a particular channel, the 
neuron is held at a holding potential of - 70 m V, the motor 
is deactivated and neuron hunting is re-started 1010 in the 
remaining active channels. This process is repeated until all 
the active channels have encountered neurons and under-
gone gigasealing 1075, following which synchronized 
break-in 1080 is attempted. 
FIGS. llA-C together comprise a flowchart showing the 
steps of a preferred embodiment of the complete generalized 
automated process for patching multiple neurons in vivo 
according to one aspect of the invention, including strategies 
for stage execution, and quantitative milestones governing 
process flow and decision making There are four stages of 
the process, Setup 1002, Regional pipette localization 1104, 
Neuron hunting and Gigasealing 1104, and Break-in 1108, 
and within each stage the symbols depicted in FIGS. llA-C 
represent tasks, measurements, and choice points. Abbre-
viations used in the steps depicted in FIGS. llA-C include: 
ACSF, artificial cerebrospinal fluid; RZO,, resistance of 
pipette i at depth Z in the brain, in microns (with the z-axis 
pointing downward, e.g. larger values of Z indicate deeper 
targets); upper depth limit of the region targeted by the 
regional pipette localization stage; Zl, lower depth limit of 
the region targeted by the regional pipette localization stage 
of each pipette i; R(Z,Neuron), pipette resistance at the depth 
at which the neuron is being recorded (which will vary over 
time, as the later stages of the process, gigasealing and 
breaking-in, occur); and Rt, pipette resistance threshold for 
neuron detection. The blocks shown in Setup 1102 are 
manual tasks that are carried out by the experimenter, while 
the remaining blocks are executed by a computer. 
In FIGS. llA-C, during setup stage 1102, for each new 
attempt 1110, pipettes are placed 1111 in the holder, excess 
artificial cerebrospinal fluid (ACSF) may be removed 1112 
from the brain surface, and pressure switching units are reset 
to the default configuration 1113. Pipette tips are positioned 
1114 above the brain surface, the brain surface is superfused 
1115 with ACSF, and regional pipette localization 1104 is 
initiated 1116. During regional pipette localization stage 
1104, pipette resistances are checked 1117 and bad pipettes 
are deactivated 1118. For the remaining pipettes, the robot 
lowers 1119 the pipettes at a speed of 200 µmis to the 
appropriate depth for neuron hunting and then reduces 1120 
the internal valve pressure to low positive pressure for all 
channels. Pipettes are then assessed for blockages 1122, with 
blocked pipettes being deactivated 1123. Regional pipette 
localization is ended 1124, and if all pipettes have been 
either gigasealed or deactivated 1125, the trial is stopped 
1126. 
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moving them 1137, and checking 1138 for neuron encoun-
ters. If, as determined 1150 by a time series of resistance 
measurements, no neuron has been encountered after the 
pipette distance has been repeatedly adjusted for a pipette 
and the maximum probe depth has been reached 1151, the 
pipette is deactivated 1152. If, as determined by the resis-
tance measurements, a neuron has been encountered for a 
particular pipette, gigaseal formation is initiated 1160 for 
that pipette, after a pause 1161 to check 1162 for false 
10 
positives, starting with release 1163 of positive pressure on 
the pipette and, if necessary, application 1165 of suction 
pressure. This process is continued until gigaseal formation 
or deactivation has occurred for all pipettes. Once gigaseal 
formation is achieved and verified for all active pipettes 
1170, break-in stage 1108 is initiated 1171. During this 
15 stage, pipettes are checked for deactivation 1173, and active 
pipettes are checked for spontaneous break-in 1175. Those 
pipettes without spontaneous break-in are checked for viable 
cells 1176, and for those with viable cells break-in is 
initiated 1180 by application 1182 of suction, leading hope-
20 fully to a successful whole cell patch clamp 1185. When 
break-in has been attempted or achieved for all pipettes with 
viable cells, the multipatcher process is completed 1190. 
Performance of the multipatching robot. The performance 
of a 4-channel multipatching robot was validated in the 
25 cortex of anesthetized mice. The multipatcher, running the 
process shown in FIGS. 4 and llA-C, obtained successful 
whole cell recordings in 1 or more channels 58.9% of the 
time (n=23 out of 39 trials, n=7 mice). Success was defined 
as being able to hold a cell in current clamp mode with under 
30 
500 pAof injected current for at least 5 minutes. Out of these 
23 trials, the multipatcher successfully recorded from pairs 
of neurons in 11 trials and from a triplet of neurons in one 
trial. Thus overall, the multipatcher was able to establish 
successful whole cell recordings from multiple neurons 
30.76% of the time (12 out of 39 attempts). The ability to 
35 record from pairs and triplets of cells simultaneously dem-
onstrates the scalability of the multipatching robot process; 
by increasing the number of controllable pipettes, even 
higher numbers of simultaneous whole cell recordings can 
be obtained. In these trials, overall, 17.9% of the pipettes got 
40 blocked (n=28 of 156 pipettes in n=39 trials), a percentage 
that is comparable to those obtained when using the single 
channel autopatcher. The entire multipatcher trial, from start 
of regional pipette localization to end of break-in, took an 
average of 10.45+2.56 minutes. Thus, per channel, the 
45 multipatcher requires 2.61+0.64 minutes, which is again 
comparable to the time taken by the single channel auto-
patcher to establish whole cell recordings. 
During neuron hunting and gigasealing stage 1106, neu-
ron hunting is initiated 1130. The robot checks a pipette for 
deactivation 1132, and if it is not deactivated, the robot 
iteratively moves 1133 the pipette and measures 1134 the 50 
resistance in order to determine whether or not a neuron has 
been encountered. This is repeated until all pipettes have 
been moved 1133 and checked 1134. This process is itera-
tively repeated, checking pipettes for deactivation 1136, 
When the multipatcher attempts break-in, the user can 
choose the channels in which break-in needs to be executed. 
An iterative method was used wherein the duration of the 
suction pulses and the applied pressures were incremented in 
each successive attempt, until a successful break-in was 
formed. Table 1 reports pressure and time setting for itera-
tively achieving successful break in, while causing as mini-
mal perturbation to the cell as possible. 
TABLE 1 
200 ms 250 ms 300 ms 350 ms 400 ms 450 ms 500 ms 750 ms 1000 ms 
150 KPa Attempt Attempt Attempt Attempt Attempt Attempt Attempt Attempt Attempt 
1 2 3 4 5 6 21 22 23 
200 KPa Attempt Attempt Attempt Attempt Attempt Attempt Attempt Attempt 
7 8 9 10 11 24 25 26 
250 KPa Attempt Attempt Attempt Attempt Attempt 
12 13 14 15 16 
300 KPa Attempt Attempt Attempt Attempt 
17 18 19 20 
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Using this process, successful gigasealed cell attached 
recordings were obtained from 35.93% of the active pipettes 
( 46 out of 128 pipettes in 39 trials, 28 pipettes were 
deactivated at the end of the regional pipette localization 
stage). This was the highest yield obtained from all three 
iterations and was thus used as the final generalized process 
(shown in flowchart form in FIGS. llA-C). Of the 46 
neurons that were gigasealed, successful whole cell record-
ings were established in 36 neurons, achieving a break-in 
success rate of 78.2%. Successful whole cell recordings 
from multiple neurons, i.e. 2 or 3, were established in 30.7% 
(12 out of the 39 trials, with 11 recordings where pairs of 
neurons were connected, and 1 recording where a triplet of 
neurons were recorded) of the trials, but whole cell record-
ings in all 4 pipettes were not achieved in any of the trials. 
While the process was formulated and tested using a 4-chan-
nel multipatcher system, it will be clear to one of skill in the 
art that the methodology and apparatus of the invention can 
be applied to control arrays of arbitrarily large number of 
pipettes. More pipettes would ensure, higher success rate of 
obtaining multiple patch recordings. 
Time course of Multipatcher operation. A representative 
trace of resistance readings recorded from the four channels 
of the multipatcher during a full trial is shown in the graph 
in FIG. 12. The resistance traces are shown for channels 1 
(1210), 2 (1220), 3 (1230), and 4 (1240). The key events 
during the trial are denoted by time dividing lines 1245, 
1250, 1255, 1260, 1265, 1270, 1275, 1280, 1285, 1290, 
1295. The detection of a neuron by channel 3 1230 is shown 
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m V holding potential at the end of the 60-second gigasealing 
process. Thus, even as the program resumed neuron hunting 
with pipettes that were yet to encounter neurons, the gigas-
ealed cell's or cells' seal resistance continued to increase 
and finally asymptote due to the hyperpolarizing holding 
potential that was applied. This did not, however, apply to 
the channel that attempted gigasealing last, for which the 
usual conditions used for autopatching were applied. 
In a subset of the trials, the time taken to fill, install, and 
10 position the pipettes in a multipatching trial was measured. 
For four channels, the average time taken for filling and 
installing pipettes was 12.48+ 1.36 minutes (n=l 8 trials), and 
the time taken for the completion of multipatcher trials 
15 culminating in successful whole cell recordings of one of 
more neurons was 10.45+2.56 minutes (n=14 trials). Thus, 
for a single channel, it takes 3.2+0.31 minutes for pipette 
installation, and 2.61±0.64 minutes for whole cell patch 
clamping, as compared to the autopatcher, which requires 
20 2.0±0.4 minutes for pipette installation and 5±2 minutes for 
operation. The increased time for pipette installation per 
channel is due to the increased complexity of tasks involved 
in positioning the pipettes in close confinement. However, 
this is offset somewhat by the reduced time for operation/ 
25 channel, mainly due to limiting the gigasealing operations of 
all but one channel to 60 seconds. 
If the current system were to be scaled up for controlling 
at time 1245. Between time 1245 and time 1250, all pipettes 30 
paused neuron hunting and stopped advancing, and gigas-
ealing was attempted in channel 3 1230. The gigasealing 
tasks were carried out as previously described at time 1250, 
higher numbers of pipettes, it is expected that installation 
and robot operation times would scale up proportionally, 
with the time for installation increasing more rapidly. Thus 
scaling up beyond 10-12 channels would benefit from a 
redesign of the actuation modules in order to enable quick 
replacement of pipettes for high-throughput operation. 
set at - 70 m V. The entire gigasealing process was pro-
grammed to execute in 60 seconds. At the end of 60 seconds, 35 
channel 3's motor was deactivated and the holding potential 
held at - 70 m V, as the rest of the channels resumed neuron 
hunting. At time 1255, the robot detected contact with a 
neuron in channel 2 1220. The same gigasealing steps 
described previously for channel 3 1230 were used for 40 
channel 2 1220 between times 1255 and 1260, resulting in 
Quality of patch recordings. Representative voltage traces 
recorded simultaneously from a triplet of neurons in current 
clamp mode that were simultaneously whole cell recorded 
using the multipatcher are shown in FIG. 13A. The three 
neurons were targeted in the motor cortex, - 700 microm-
eters from each other. Mean resting potentials for the neu-
rons were -55.93+7.21 mV (top 1310), -60.3+4.52 mV 
(center 1320) and -69.23+4.58 mV (bottom 1330). As 
an unsuccessful gigaseal formation. It must be noted that 
gigasealing was attempted only for 35 seconds, as opposed 
to the full 60 second routine. Because it was clear that the 
cell would not gigaseal, the experimenter terminated the 
gigasealing attempt using a manual intervention mechanism 
in the software interface. At time 1260, channel 2's motor 
was deactivated, at the end of which the holding potential 
was held at - 70 m V, while channels 1 1210 and 4 1240 
resumed neuron hunting. Between time 1265 and time 1270, 
the robot paused again, to successfully attempt a gigaseal 
formation in channel 1 1210. Finally, the same sequence of 
events was applied to channel 4 1240, and a successful 
gigaseal resulted between time 1280 and time 1290. At time 
1295, the gigasealed neurons attached to the patch elec-
trodes in channels 1 1210, 3 1230, and 4 1240 were broken 
into to establish whole cell patch recordings. 
An important distinction from the autopatcher process is 
to be noted. The time for execution of gigasealing tasks was 
fixed at 60 seconds, whereas in the autopatcher, break-in was 
initiated at the discretion of the experimenters. Thus, aver-
age gigasealing time reported for the autopatcher is higher 
than 60 seconds. The gigasealing times recorded for auto-
patching are the times taken for gigaseals to fully stabilize 
and asymptote, upon which break-in was initiated by the 
experimenter. In the multipatcher process, a fixed time was 
employed for gigasealing with the cell being clamped at - 70 
observed previously with the autopatcher, a majority of the 
neurons exhibited up and down states, typical of cortical 
neurons under anesthesia. The up and down states in all 
45 neurons were highly correlated, as can be seen in FIG. 13B, 
which is a detail view of sub-threshold membrane potential 
fluctuations during the time highlighted by dashed box 1340 
in FIG. 13A. Neurons recorded displayed a high degree of 
correlation in the up and down state fluctuations. Spikes in 
50 this time period have been truncated for better visualization. 
Currents were injected in the neurons recorded in FIGS. 
13A-B to determine if they evoke synaptic currents in other 
neurons. FIGS. 14A-C are current traces showing the results 
of investigation of synaptic connectivity between whole cell 
55 patched neurons using the neurons recorded in FIGS. 13A-
B. As shown in FIG. 14A, 80 pA of somatic current injection 
in the neuron shown in the top trace 410 elicited no response 
in the other two cells 420, 430 despite spiking. As shown in 
FIG. 14B, 120 pA current in the neuron recording shown in 
60 the middle trace 420, and in FIG. 14C, 60 pA current 
injection into the neuron recording shown in the bottom 
trace 430; again, no synaptic response was evoked in the 
other neurons. Evoked synaptic currents were not seen in 
any of the paired recordings, possibly because it was not 
65 within the range of distances where one would expect a high 
probability of synaptically connected neurons. This obser-
vation was consistent with other paired recordings. 
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Stable recording from multipatched cells for 56+8 min-
utes (n=23 neurons) was achieved, with recordings lasting 
for a maximum of 90 minutes. In the interest of throughput, 
the recordings were prematurely terminated in 5 trials (3 
paired recordings, 2 single neuron recordings), before the 
whole cell recordings were lost, thus, the actual average 
recording time could have been higher. 
Analyzing just the trials where multiple whole cell record-
ings were obtained, the mean and standard deviation of the 
access resistances obtained were 44.2+17.6 MQ (n=23 neu-
rons), the mean and standard deviation of the resting mem-
brane potentials were -62.2+9.8 mV (n=23 neurons), and 
the mean and standard deviation of the currents needed to 
hold the neurons at -65 m V in voltage clamp mode was 
-78.5+55.2 pA (n=23 neurons). All of these values are 
comparable those obtained previously by us using the single 
channel autopatcher, suggesting that holding cells for pro-
longed periods of time (>2-3 minutes) did not affect the 
quality of the whole cell recordings. 
The whole cell patched neurons were grouped into those 
that were gigasealed immediately upon detection, and those 
that were held in gigasealed states for longer periods of time 
during neuron hunting in other channels. Between these two 
groups, the access resistances and the resting membrane 
potentials were compared, being indicators of the quality of 
the recording obtained. All parameters reported here are in 
the uncompensated form (i.e. no series resistance or capaci-
tance compensation), obtained using the conventional patch 
clamp software after autopatcher program completion. Pre-
vious literature has suggested that holding neurons for 
prolonged periods of time in gigaseal cell attached state 
leads to higher access resistances. Further, it was desired to 
assess the effect, if any, that tissue displacement had on these 
gigasealed neurons. The mean and standard deviation of the 
access resistances were 49.4+23.9 MQ (n=8 cells that were 
successfully broken into immediately upon establishment of 
gigaseal), and 41.4+14.6 49.4+23.9 MQ (n=15 cells that 
were gigasealed held in that state when other channels were 
conducting neuron hunting). No statistically significant dif-
ference was found in the access resistances of the two 
datasets (t-test, p>0.86). 
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dampening the motion artifacts of the brain, 2% agarose was 
used to cover the brain surface. Experiments typically lasted 
5 hours, at the end of which the mice were euthanized via 
cervical dislocation when fully anesthetized. 
Electrophysiology. Borosilicate glass pipettes (Warner) 
with resistances between 3-9 MW were pulled using a 
filament micropipette puller (Flaming-Brown P97 model, 
Sutter Instruments) and stored in a closed petri dish to 
reduce dust contamination. During each experiment at least 
10 60-70 pipettes were used. They were filled with intracellular 
pipette solution consisting of (in mM): 125 potassium glu-
conate (with more added empirically at the end, to bring 
osmolarity up to -290 mOsm), 0.1 CaC12 , 0.6 MgC12 , 1 
EGTA, 10 HEPES, 4 Mg ATP, 0.4 Na GTP, 8 NaCl (pH 7.23, 
15 osmolarity 289 mOsm), as used in the past. 
Multipatcher robot operation. The first step of the process 
started with the pipettes having been installed in the holders. 
A program valve_reset.vi was executed in Labview to con-
figure the pressure switching board to its default configura-
20 tion, resulting in all pipettes being maintained in high 
positive pressure state. 3-axis linear actuators (Sutter Instru-
ments) were employed to manually position the pipette tips 
over the craniotomy (or multiple craniotomies) 20-30 mm 
above the brain surface using a control joystick with the aid 
25 of a stereomicroscope (Nikon). The pipette voltage offsets 
were automatically nullified by the "pipette offset" function 
in the Multiclamp Commander (Molecular Devices) and the 
Multipatcher_verl.O.vi program initiated. 
The multipatcher represents the first demonstration of a 
30 scalable platform capable of conducting multidimensional 
single cell measurements at the neuronal circuit level. For 
the first time, a realistic solution for linking cellular level 
measurements to systems level characterization in the intact 
brain has emerged. The processes developed for the multi-
35 patcher build on the existing autopatcher process that has 
been previously reported (U.S. patent application Ser. No. 
13/676,082, filed Nov. 13, 2012) and take into consideration 
the mechanical interactions of pipettes and the surrounding 
brain tissue while being actuated. The quality of recordings 
40 obtained with the mutlipatcher robot was comparable to the 
quality of recordings obtained with the single channel auto-
patcher system. When combined with custom hardware, it is 
thus scalable to control arbitrarily large numbers of pipettes 
in the intact brain. Further, if the hardware can be minia-
Experimental Methods. Surgical procedures were con-
ducted in a manner similar to those described previously in 
U.S. patent application Ser. No. 13/676,082. All animal 
procedures were approved by the MIT Committee on Ani-
mal Care. Adult male C57BL/6 mice (Taconic), 8-12 weeks 
old, were anesthetized using ketamine/xylazine (initially at 
100 mg/kg and 10 mg/kg, and redosed at 30-45 minute 
intervals with 10-15% of the initial ketamine dose as needed, 
using toe pinch reflex as a standard metric of anesthesia 
depth). The scalp was shaved, and the mouse placed in a 
custom stereotax, with ophthalmic ointment applied to the 
eyes, and with Betadine and 70% ethanol used to sterilize 
the surgical area. Three self-tapping screws (FOOOCE094, 
Morris Precision Screws and Parts) were attached to the 55 
skull and a plastic headplate affixed using dental acrylic. 
Once set (-20 minutes), the mice were removed from the 
stereotax and placed in a custom-built low profile holder. A 
dental drill was used to open up 4 craniotomies (0.25-0.5 
mm diameter, within a spacing of 1 mm) by thinning the 
skull until -100 µm thick, and then a small aperture was 
opened up with a 30 gauge needle tip. Cortical craniotomies 
were opened at stereotaxic coordinates: anteroposterior, 
-1.5 to +O mm relative to bregma; mediolateral, 1-3 mm left 
45 turized with better precision in placement within much 
smaller regions spanning local microcircuits (<200 µm), it 
can be used to assess synaptic connectivity between neurons 
in a microcircuit in the intact brain. Multiple electrodes can 
also be used to record from varied interconnected regions of 
50 the brain, opening up possible experiments to assess how 
sub-threshold membrane potential fluctuations are corre-
lated across these regions, such sensory thalamo-cortical 
circuits, or even more dynamic processes like memory 
formation. 
The scalability in the electrode numbers means that the 
multipatcher can be used as a high-throughput tool for 
systematically obtaining large electrophysiological datasets 
for analyzing brain circuits. If combined with processes that 
enable automated single cell RNA harvesting, the robot can 
60 be used to probe and obtain genetic information from large 
numbers of cells. Such a strategy can be generalized to other 
frontiers in biology, bioengineering, and medicine, in which 
the assessment of the properties of single cells, embedded 
within intact tissue, is desired but has not previously been 
or right of the midline; neuron hunting typically began at a 
depth of -400 µm depth. The dura was removed using a pair 
of fine forceps, or in some instances, not removed at all. For 
65 achievable in a systematic high-throughput fashion. For 
example, analyzing how different cells in a neural circuit 
respond to a drug in specific brain states, performing elec-
US 9,498,293 B2 
21 
trical characterizations of cells in tissues removed during 
surgery, determining how different individual cells within a 
tumor biopsy sample vary in gene expression, and assessing 
how tissue-engineered organs vary in cell to cell composi-
tion, may provide fundamental new capabilities in diagnos-
tics, personalized medicine, and drug development. 
Further, the hardware architecture makes it amenable to 
integration with optical components for optogenetic stimu-
lation. This combined approach will enable assessments of 
the synaptic basis of how specific cell types coordinate 10 
network activity. The multipatcher opens up several inter-
esting engineering challenges for scaling up. Currently, there 
are some limitations to the number of electrodes that can be 
simultaneously manipulated using these actuator systems 
due to their macroscopic scale. Attempting to build very 15 
large arrays using conventional apparatus would run into 
stereotactic hindrance within 6-12 pipettes. Alternate strat-
egies for miniaturizing the actuation systems, as well as 
using novel electrodes such as flexible fused silica pipettes 
can be explored. Since patch pipettes can be used only once, 20 
scaled up multipatchers will require hundreds of pipettes to 
be fabricated, filled, and assembled for each experiment 
( 60-70 pipettes are currently used in a typical day, taking -1 
hour to fabricate them). Thus developing a means to fabri-
cate pipettes in an automated fashion can be advantageous. 25 
The time taken to assemble these pipette arrays will also 
increase proportionally with electrode numbers. Thus, strat-
egies for automated filling and assembly of pipettes would 
be advantageous. Alternately, protocols can be developed to 
re-use assembled multipatcher arrays by attempting to clean 30 
pipettes tips or the hardware can be developed so as to allow 
robotic assembly of pipettes. Denser pipette arrays will 
increase the tissue displacement effects, and thus newer 
pipette geometries with thinner shanks, will be needed. 
Finally, as the number of channels increase, the cost of the 35 
amplifiers will be significant. Thus, use of low cost ampli-
fiers dedicated for patch clamping would be advantageous in 
order to reduce the cost of patching. 
While a preferred embodiment is disclosed, many other 
implementations will occur to one of ordinary skill in the art 40 
and are all within the scope of the invention. Each of the 
various embodiments described above may be combined 
with other described embodiments in order to provide mul-
tiple features. Furthermore, while the foregoing describes a 
number of separate embodiments of the apparatus and 45 
method of the present invention, what has been described 
herein is merely illustrative of the application of the prin-
ciples of the present invention. Other arrangements, meth-
ods, modifications, and substitutions by one of ordinary skill 
in the art are therefore also considered to be within the scope 50 
of the present invention, which is not to be limited except by 
the claims that follow. 
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determining whether or not a target cell has been 
encountered by one or more of the electrodes by 
constructing a temporal series of the electrical prop-
erty measurements during or after at least one itera-
tion of the steps of moving and making; 
iteratively continuing the steps of moving, making, and 
determining until the temporal series of electrical 
property measurements for one or more of the elec-
trodes, over a threshold number of consecutive itera-
tions, indicates a predefined signature of electrode 
change that has passed a pre-set target cell detection 
threshold, wherein having a predefined signature of 
electrode change that passes the target cell detection 
threshold indicates that an electrode has encountered 
a target cell; 
initiating connection formation for any electrodes that 
have encountered a target cell; 
repeating the steps of continuing, pausing, and initiat-
ing until one or more of the plurality of electrodes 
has encountered a target cell; and 
assessing whether or not connection formation has been 
achieved at the electrodes. 
2. The method of claim 1, further comprising the step of: 
if connection formation has been achieved, initiating 
break-in and formation of whole-cell patch clamps. 
3. The method of claim 2, further comprising the step of 
verifying formation of the whole-cell patch clamps. 
4. The method of claim 1, further comprising the steps of: 
providing positive pressure to the cell patch clamping 
devices during the step of localizing; and 
after completing the step of localizing, 
reducing the pressure provided to the cell patch clamp-
ing devices to low positive pressure; 
measuring the electrical property at the electrode tips; 
assessing whether or not the electrical property has 
passed a pre-set tip blockage threshold at any of the 
electrode tips; and 
if the electrical property has passed the pre-set tip 
blockage threshold for any of the electrode tips, 
retracting the associated cell patch clamping devices 
to indicate tip blockage and failure. 
5. The method of claim 4, wherein the step of initiating 
connection formation further comprises the step of releasing 
the positive pressure applied to the cell patch clamping 
devices. 
6. The method of claim 5, further comprising the steps of: 
after the step of assessing, if connection formation has not 
been achieved for all tips, applying suction pressure to 
the cell patch clamping devices for which connection 
formation has not been achieved; and 
re-assessing whether or not connection formation has 
been achieved for all tips. 
What is claimed is: 
1. A method for automated multiple whole-cell patch 
clamping, comprising the steps of: 
7. The method of claim 2, wherein the step of initiating 
break-in and formation further comprises applying at least 
55 one of suction and an electrical pulse to the cell patch 
clamping devices. in an automated apparatus for multiple cell patch clamp-
ing that is under the control of a computer processor, 
localizing a plurality of electrodes, each electrode of 
the plurality of electrodes having a tip and being 
associated with one of a plurality of cell patch 60 
clamping devices, by causing the tips of the elec-
trodes to be moved to a predetermined location for 
cell hunting; 
moving the tips of the plurality of electrodes by a 
defined amount; 
making an electrical property measurement at each of 
the electrode tips during or after the step of moving; 
65 
8. The method of claim 1, further comprising the step of: 
if a predetermined maximum level for moving the elec-
trodes has been reached, retracting the cell patch 
clamping devices to indicate cell location failure. 
9. A method for achieving and verifying multiple cell 
contact in an automated electrophysiology device, compris-
ing the steps of: 
in an automated electrophysiology apparatus that is under 
the control of a computer processor, 
localizing a plurality of electrodes of the electrophysi-
ology apparatus, each of the plurality of electrodes 
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having a tip, by causing the tips of the electrodes to 
be moved to a predetermined location for cell hunt-
ing; 
moving the tips of the plurality of electrodes by a 
defined amount; 
making an electrical property measurement at each of 
the electrode tips during or after the step of moving; 
24 
14. The apparatus of claim 13, wherein the controllable 
plurality of pneumatic valves is configured for providing 
positive pressure to the cell patch clamping devices while 
the tips of the electrodes are moved to a predetermined 
location for cell hunting. 
15. The apparatus of claim 13, wherein the controllable 
plurality of pneumatic valves is configured for reducing the 
pressure provided to the cell patch clamping device to low 
positive pressure after the tip of the electrode has been 
determining whether or not a target cell has been 
encountered by any of the electrode tips by con-
structing a temporal series of the electrical property 
measurements during or after at least one iteration of 
the steps of moving and making; and 
10 moved to a predetermined location for cell hunting; and 
the automated control system is further configured for: 
measuring an electrical property at the electrode tips; 
assessing whether or not the measured electrical prop-
erty has passed a pre-set tip blockage threshold at 
any of the electrode tips; and 
iteratively continuing the steps of moving, making, and 
determining until the temporal series of electrical 
property measurements for one or more of the elec- 15 
trodes, over a threshold number of consecutive itera-
tions, indicates a predefined signature of electrode 
change that has passed a pre-set cell detection thresh-
old that indicates that cell contact has been achieved. 
10. An apparatus for automated multiple cell patch clamp- 20 
ing, comprising: 
a cell patch formation apparatus, comprising: 
a plurality of cell patch clamping devices, each cell 
patch clamping device comprising: 
an associated electrode, the electrode having a tip 25 
and; 
a 3-axis linear actuator configured for positioning the 
cell patch clamping device; 
a patch amplifier with computer interface; and 
if the measured electrical property has passed the 
pre-set tip blockage threshold for any of the elec-
trode tips, directing the linear motor to retract the 
associated cell patch clamping device to indicate tip 
blockage and failure. 
16. The apparatus of claim 15, wherein the controllable 
plurality of pneumatic valves is further configured for 
releasing the positive pressure applied to the cell patch 
clamping devices during initiation of connection formation. 
17. The apparatus of claim 16, wherein the controllable 
plurality of pneumatic valves is further configured for apply-
ing suction pressure to the cell patch clamping devices if 
connection formation has not been achieved. 
18. The apparatus of claim 16, wherein the controllable 
a progranimable linear motor configured for moving 
the cell patch clamping devices up and down in a 
temporally precise fashion; and 
a computer interface configured for automated closed-
loop control of the programmable linear motors 
based upon a temporal series of electrical property 
measurements made at the tips of the electrodes. 
30 plurality of pneumatic valves further applies at least one of 
suction and an electrical pulse to the cell patch clamping 
devices to initiate break-in and whole-cell patch clamp 
formation. 
19. A method for controlling an automated multiple cell 
35 patch clamping device, comprising the steps of: 
11. The apparatus of claim 10, further comprising an 
automated control system configured for: 
causing the tips of the electrodes to be moved to a 
predetermined location for cell hunting; 
iteratively causing the tips of the electrodes to be moved 
by a defined amount; 
making an electrical property measurement at the elec-
trode tips during or after each movement; 
40 
determining whether or not a target cell has been encoun- 45 
tered by any of the electrode tips by constructing a 
temporal series of the electrical property measurements 
during or after at least one iteration of moving and 
making; 
iteratively causing continuation of moving, making, and 50 
determining until the temporal series of electrical prop-
erty measurements for one or more of the electrodes, 
over a threshold number of consecutive iterations, 
indicates a predefined signature of electrical change 
that has passed a pre-set cell detection threshold; 55 
initiating connection formation; and 
assessing whether or not connection formation has been 
achieved at the electrodes. 
12. The apparatus of claim 11, wherein the automated 
control system is further configured for initiating break-in 60 
and formation of whole-cell patch clamps if connection 
formation has been achieved and verifying formation of the 
whole-cell patch clamps. 
13. The apparatus of claim 11, further comprising a 
controllable plurality of pneumatic valves configured for 65 
application of pressure and suction to the cell patch clamp-
ing devices. 
in a cell patch formation apparatus, comprising: 
a plurality of cell patch clamping devices, each having 
an associated electrode, the associated electrode hav-
ing a tip; 
a 3-axis linear actuator configured for positioning each 
cell patch clamping device; 
a patch amplifier with computer interface; 
a programmable linear motor configured for moving 
the cell patch clamping devices in a temporally 
precise fashion; and 
a computer interface configured for closed-loop control 
of the programmable motor based upon sequences of 
electrical property measurements made at the tips of 
the electrodes, 
localizing the electrodes by causing the linear motor to 
move the tip of the electrodes to a predetermined 
location for cell hunting; 
causing the linear motor to iteratively move the tips of the 
electrodes by a defined amount; 
measuring the electrical property at the electrode tips 
during or after the step of moving; 
determining whether or not a target cell has been encoun-
tered by any of the cell patch clamping devices by 
constructing a temporal series of the electrical property 
measurements during or after at least one iteration of 
the steps of moving and measuring; 
iteratively continuing the steps of moving, measuring, and 
determining until the temporal series of electrical prop-
erty measurements for one or more of the electrodes, 
over a threshold number of consecutive iterations, 
indicates a predefined signature of electrode change 
that has passed a pre-set target cell detection threshold, 
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wherein having a predefined signature of electrode 
change that passes the target cell detection threshold 
indicates that an electrode has encountered a target cell· 
causing the linear motor to pause the electrodes; ' 
initiating connection formation for any electrodes that 
have encountered a target cell; 
assessing whether or not connection formation has been 
achieved; 
if connection formation has been achieved, optionally 
initiating break-in and formation of at least one whole- 10 
cell patch clamp; and 
optionally verifying formation of the whole-cell patch 
clamps. 
20. The method of claim 19, wherein the cell patch 
formation apparatus further comprises a controllable plural- 15 
ity of pneumatic valves configured for application of pres-
sure and suction to the cell patch clamping devices and 
further comprising the steps of: 
providing positive pressure from the controllable plurality 
of pneumatic valves to the cell patch clamping devices 20 
during the step of localizing; 
after completing the step of localizing, 
reducing the pressure provided to the cell patch clamp-
ing devices to low positive pressure; 
26 
measuring the electrical property at the electrode tips; 
assessing whether or not the electrical property has 
passed a pre-set tip blockage threshold; and 
if the electrical property has passed the pre-set tip 
blockage threshold for any of the electrode tips, 
retracting the associated cell patch clamping device 
to indicate tip blockage and failure; 
wherein the step of initiating connection formation 
further comprises releasing the positive pressure 
applied to the cell patch clamping devices; 
after the step of assessing, if connection formation has not 
been achieved, 
applying suction pressure from the controllable plural-
ity of pneumatic valves to the cell patch clamping 
devices; and 
re-assessing whether or not connection formation has 
been achieved; and 
wherein the step of initiating break-in and formation 
further comprises applying to the cell patch clamping 
devices at least one of: suction pressure from the 
controllable plurality of pneumatic valves and an elec-
trical pulse. 
* * * * * 
